Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT06745622 · RECRUITING
Trial details
- NCT number
- NCT06745622
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-03
- Primary completion
- 2027-06-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.